Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04371861 · ClinicalTrials.gov registry record
Observational Study to Assess Transradial Access for Treatment in the Lower Extremities.
A clinical trial, sponsored by Terumo Medical Corporation.
- Completed
- Registry status
- 120
- Enrollment target
NCT04371861: Completed study, sponsored by Terumo Medical Corporation.
NCT04371861 is a clinical trial that has completed, run by Terumo Medical Corporation. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04371861 has completed, sponsored by Terumo Medical Corporation.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
This study is designed to collect data on the complication rates and procedural success of using a transradial access approach to treat peripheral lesions in the lower extremities of a real world population.
Primary Outcome
Rates of occurrence in complications associated with transradial access.
Interventions
- DEVICE Peripheral Artery Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2020-06-29 |
| Est. Completion | 2022-06-30 |
What the finished NCT04371861 record still lists
NCT04371861 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Peripheral Artery Treatment is the first listed.
NCT04371861 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04371861 about?
NCT04371861 is a clinical study titled "Observational Study to Assess Transradial Access for Treatment in the Lower Extremities.". This study is designed to collect data on the complication rates and procedural success of using a transradial access approach to treat peripheral lesions in the lower extremities of a real world population.
What is the current status of trial NCT04371861?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2020-06-29. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT04371861?
The interventions under investigation include: Peripheral Artery Treatment (DEVICE).
Who is sponsoring clinical trial NCT04371861?
This trial is sponsored by Terumo Medical Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI